TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons June 1, 1984